MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 156 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $49,224,000 | +18.4% | 1,479,524 | -3.2% | 2.96% | -15.1% |
Q1 2020 | $41,560,000 | +25.0% | 1,527,956 | -9.3% | 3.48% | +90.1% |
Q4 2019 | $33,252,000 | +46.0% | 1,685,372 | -4.1% | 1.83% | +20.7% |
Q3 2019 | $22,772,000 | -4.7% | 1,757,122 | -8.5% | 1.52% | +30.6% |
Q2 2019 | $23,895,000 | -10.7% | 1,919,313 | +4.2% | 1.16% | +4.1% |
Q1 2019 | $26,759,000 | +31.6% | 1,841,613 | 0.0% | 1.12% | +3.1% |
Q4 2018 | $20,331,000 | -57.8% | 1,841,613 | +0.4% | 1.08% | -44.5% |
Q3 2018 | $48,222,000 | +28.6% | 1,833,532 | 0.0% | 1.95% | +30.1% |
Q2 2018 | $37,496,000 | +12.9% | 1,833,532 | +0.2% | 1.50% | +5.4% |
Q1 2018 | $33,222,000 | +30.7% | 1,830,435 | +0.5% | 1.42% | +29.9% |
Q4 2017 | $25,411,000 | -23.5% | 1,821,576 | +1.5% | 1.09% | -21.8% |
Q3 2017 | $33,207,000 | +9.9% | 1,794,998 | +0.4% | 1.40% | -0.8% |
Q2 2017 | $30,210,000 | +28.6% | 1,787,576 | +1.6% | 1.41% | +27.0% |
Q1 2017 | $23,488,000 | -9.7% | 1,759,376 | +1.9% | 1.11% | -25.2% |
Q4 2016 | $25,997,000 | +34.7% | 1,727,380 | +4.6% | 1.48% | +32.3% |
Q3 2016 | $19,299,000 | +9.7% | 1,650,876 | +1.3% | 1.12% | -15.7% |
Q2 2016 | $17,594,000 | +29.6% | 1,629,076 | +10.9% | 1.33% | +26.2% |
Q1 2016 | $13,571,000 | -37.7% | 1,468,776 | 0.0% | 1.05% | -13.2% |
Q4 2015 | $21,797,000 | -8.7% | 1,468,776 | +0.9% | 1.21% | +5.7% |
Q3 2015 | $23,879,000 | -28.1% | 1,455,176 | 0.0% | 1.15% | -22.2% |
Q2 2015 | $33,193,000 | +50.1% | 1,455,176 | 0.0% | 1.48% | +34.9% |
Q1 2015 | $22,119,000 | +26.2% | 1,455,176 | 0.0% | 1.09% | +6.4% |
Q4 2014 | $17,520,000 | +6.2% | 1,455,176 | 0.0% | 1.03% | -16.6% |
Q3 2014 | $16,502,000 | -6.1% | 1,455,176 | 0.0% | 1.23% | -5.8% |
Q2 2014 | $17,579,000 | -42.6% | 1,455,176 | -44.7% | 1.31% | +3.3% |
Q1 2014 | $30,638,000 | +49.7% | 2,629,952 | +127.3% | 1.27% | -33.6% |
Q4 2013 | $20,461,000 | +25.1% | 1,157,276 | +1.8% | 1.91% | +11.4% |
Q3 2013 | $16,357,000 | -7.6% | 1,136,676 | -3.3% | 1.71% | -18.0% |
Q2 2013 | $17,697,000 | – | 1,175,076 | – | 2.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 159,197 | $5,296,000 | 4.06% |
Ghost Tree Capital, LLC | 385,000 | $12,809,000 | 3.38% |
Copernicus Capital Management, LLC | 88,000 | $2,928,000 | 3.21% |
Palo Alto Investors LP | 1,479,524 | $49,224,000 | 2.96% |
Redmile Group, LLC | 4,705,308 | $156,546,000 | 2.89% |
Avidity Partners Management LP | 1,150,000 | $38,261,000 | 2.45% |
RA Capital Management | 2,531,445 | $84,221,000 | 1.64% |
MAVERICK CAPITAL LTD | 2,314,756 | $77,012,000 | 1.62% |
Integral Health Asset Management, LLC | 150,000 | $4,991,000 | 1.50% |
PFM Health Sciences, LP | 579,994 | $19,296,000 | 1.00% |